Abstract
The left atrial appendage (LAA) is a prominent source of cardioembolic stroke in patients with nonvalvular atrial fibrillation (AF). While systemic anticoagulation is the common therapeutic choice, these medications carry many contraindications and possible complications. Epicardial and endovascular techniques for occlusion of LAA have been explored and early clinical data is accumulating. In the coming years, this data will help guide the management of AF patients at risk of bleeding as well as potentially become first-line therapy to reduce the risk of thromboembolic stroke. The purpose of this article is to review current endovascular and epicardial catheter based LAA occlusion devices and the clinical data supporting their use.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Roger VL, Go AS, Lloyd-Jones DM, Adams RJ, Berry JD, et al. Subcommittee. Heart disease and stroke statistics–2011 update: a report from the American Heart Association. Circulation. 2011;123(4):e18–209.
Su P, McCarthy KP, Ho SY. Occluding the left atrial appendage: anatomical considerations. Heart. 2008;94(9):1166–70.
Agmon Y, Khandheria BK, Gentile F, Seward JB. Echocardiographic assessment of the left atrial appendage. J Am Coll Cardiol. 1999;34(7):1867–77.
Al-Saady NM, Obel OA, Camm AJ. Left atrial appendage: structure, function, and role in thromboembolism. Heart. 1999;82(5):547–54.
Heist EK, Refaat M, Danik SB, Holmvang G, Ruskin JN, Mansour M. Analysis of the left atrial appendage by magnetic resonance angiography in patients with atrial fibrillation. Hear Rhythm. 2006;3(11):1313–8.
Madden JL. Resection of the left auricular appendix; a prophylaxis for recurrent arterial emboli. J Am Med Assoc. 1949;140(9):769–72.
Manning WJ. Atrial fibrillation, transesophageal echo, electrical cardioversion, and anticoagulation. Clin Cardiol. 1995;18(2):58–114.
Chatterjee S, Alexander JC, Pearson PJ, Feldman T. Left atrial appendage occlusion: lessons learned from surgical and transcatheter experiences. Ann Thorac Surg. 2011;92(6):2283–92.
Cox JL. Surgical treatment of atrial fibrillation: a review. Europace. 2004;5 Suppl 1:S20–9.
Sievert H, Lesh MD, Trepels T, Omran H, Bartorelli A, et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience. Circulation. 2002;105(16):1887–9.
Ostermayer SH, Reisman M, Kramer PH, Matthews RV, Gray WA, et al. Percutaneous left atrial appendage transcatheter occlusion (PLAATO system) to prevent stroke in high-risk patients with non-rheumatic atrial fibrillation: results from the international multi-center feasibility trials. J Am Coll Cardiol. 2005;46(1):9–14.
• Bayard YL, Omran H, Neuzil P, Thuesen L, Pichler M, et al. PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) for prevention of cardioembolic stroke in non-anticoagulation eligible atrial fibrillation patients: results from the European PLAATO study. EuroIntervention. 2010;6(2):220–6. This study provides a description of the procedure and recent data for the PLAATO device.
Block PC, Burstein S, Casale PN, Kramer PH, Teirstein P, et al. Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study. JACC Cardiovasc Interv. 2009;2(7):594–600.
Holmes DR, Reddy VY, Turi ZG, Doshi SK, Sievert H, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: a randomised non-inferiority trial. Lancet. 2009;374(9689):534–42.
Reddy VY, Holmes D, Doshi SK, Neuzil P, Kar S. Safety of percutaneous left atrial appendage closure: results from the Watchman Left Atrial Appendage System for Embolic Protection in Patients with AF (PROTECT AF) clinical trial and the Continued Access Registry. Circulation. 2011;123(4):417–24.
Meier B, Palacios I, Windecker S, Rotter M, Cao QL, et al. Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation. Catheter Cardiovasc Interv. 2003;60(3):417–22.
Reddy VY. Long term results of PROTECT AF: The mortality effects of left atrial appendage closure versus warfarin for stroke prophylaxis in AF. Presented at: Heart Rhythm Society 34th Annual Scientific Sessions; May 9, 2013; Denver, CO.
• Park JW, Bethencourt A, Sievert H, Santoro G, Meier B, et al. Left atrial appendage closure with Amplatzer cardiac plug in atrial fibrillation: initial European experience. Catheter Cardiovasc Interv. 2011;77(5):700–6. This study provides a description of the procedure and recent data for the Amplatzer cardiac plug device.
Lam YY, Yip GW, Yu CM, Chan WW, Cheng BC, et al. Left atrial appendage closure with AMPLATZER cardiac plug for stroke prevention in atrial fibrillation: initial Asia-Pacific experience. Catheter Cardiovasc Interv. 2012;79(5):794–800.
Lee RJ, Bartus K, Yakubov SJ. Catheter-based left atrial appendage (LAA) ligation for the prevention of embolic events arising from the LAA: initial experience in a canine model. Circ Cardiovasc Interv. 2010;3(3):224–9.
Bartus K, Bednarek J, Myc J, Kapelak B, Sadowski J, et al. Feasibility of closed-chest ligation of the left atrial appendage in humans. Hear Rhythm. 2011;8(2):188–93.
•• Bartus K, Han FT, Bednarek J, Myc J, Kapelak B, et al. Percutaneous Left Atrial Appendage Suture Ligation Using the LARIAT Device in Patients With Atrial Fibrillation: Initial Clinical Experience. J Am Coll Cardiol. 2012. doi:10.1016/j.jacc.2012.06.046. This study provides a description of the procedure and recent data for the LARIAT device.
Friedman PA, Asirvatham SJ, Dalegrave C, Kinoshita M, Danielsen AJ, et al. Percutaneous epicardial left atrial appendage closure: preliminary results of an electrogram guided approach. J Cardiovasc Electrophysiol. 2009;20(8):908–15. doi:10.1111/j.1540-8167.2009.01465.x.
Bruce CJ, Stanton CM, Asirvatham SJ, Danielsen AJ, Johnson SB, et al. Percutaneous epicardial left atrial appendage closure: intermediate-term results. J Cardiovasc Electrophysiol. 2011;22(1):64–70.
McCarthy PM, Lee R, Foley JL, Phillips L, Kanayinkal T, Francischelli DE. Occlusion of canine atrial appendage using an expandable silicone band. J Thorac Cardiovasc Surg. 2010;140(4):885–9.
Slater AD, Foley JL, Phillips L, Francischelli DE. Band occlusion of the atrial appendage. J Card Surg. 2010;25(2):156–60.
Compliance with Ethics Guidelines
Conflict of Interest
Sunil Kapur declares that he has no conflict of interest.
Moussa Mansour has been a consultant for Biosense Webster and St. Jude Medical; has received grant support from Biosense Webster, MC10, Boston Scientific; and has received travel/accommodations expenses covered or reimbursed from St. Jude Medical.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Invasive Electrophysiology and Pacing
Rights and permissions
About this article
Cite this article
Kapur, S., Mansour, M. Cather-Based Approaches to Stroke Prevention in Atrial Fibrillation. Curr Cardiol Rep 15, 419 (2013). https://doi.org/10.1007/s11886-013-0419-6
Published:
DOI: https://doi.org/10.1007/s11886-013-0419-6